Inhibition of protein kinase C activity by the antirheumatic drug auranofin
- 1 July 1989
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 38 (13) , 2087-2089
- https://doi.org/10.1016/0006-2952(89)90061-0
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Auranofin enhances phosphorylation of putative substrates of protein kinase C in human plateletsBiochemical Pharmacology, 1988
- Enhancement of Protein Kinase C-mediated EGF Receptor Phosphorylation by AuranofinScandinavian Journal of Rheumatology, 1988
- The Complete Primary Structure of Protein Kinase C—the Major Phorbol Ester ReceptorScience, 1986
- Cellular association, intracellular distribution, and efflux of auranofin via sequential ligand exchange reactionsBiochemical Pharmacology, 1986
- The role of protein kinase C in cell surface signal transduction and tumour promotionNature, 1984
- Platelet Ca2+-activated, phospholipid-dependent protein kinase: Evidence for proteolytic activation of the enzyme in cells treated with phospholipase CBiochemical and Biophysical Research Communications, 1984
- [1] Assays of protein kinasePublished by Elsevier ,1983
- Studies of the effect of auranofin, a new antiarthritic agent, on platelet aggregationInflammation, 1982